Nagpur
+919405117673
+919405117673

Bevacizumab Biosimilar 400mg Injection Exporter in India | Global Supply by Cordium Pharmaceuticals Pvt Ltd to USA, UK, Germany, UAE, Netherlands, South Africa & Brazil – Fast International Delivery

Bevacizumab Biosimilar 400mg Injection – Trusted Global Export from India

Cordium Pharmaceuticals Pvt Ltd is a leading India-based global exporter of Bevacizumab Biosimilar 400mg Injection, supplying high-quality oncology biologics to regulated and emerging pharmaceutical markets including the United States, Germany, United Kingdom, Netherlands, United Arab Emirates, South Africa, and Brazil.

We specialize in fast, compliant, and reliable pharmaceutical export services, ensuring consistent supply for hospitals, distributors, and licensed healthcare institutions worldwide.


What is Bevacizumab Biosimilar 400mg Injection?

Bevacizumab Biosimilar is a monoclonal antibody (anti-VEGF therapy) used in oncology treatment. It works by inhibiting the growth of blood vessels that supply tumors, thereby slowing cancer progression.

It is a biosimilar alternative to reference biologics and is widely used in modern cancer therapy protocols.


Medical Usage (Indications)

Bevacizumab Biosimilar 400mg Injection is commonly used in the treatment of:

  • Metastatic colorectal cancer
  • Non-small cell lung cancer (NSCLC)
  • Kidney (renal cell) cancer
  • Glioblastoma (brain tumors)
  • Cervical cancer
  • Ovarian and fallopian tube cancers

Administration must be done only under the supervision of qualified oncology specialists.


Dosage Information

  • Dosage is strictly determined by the treating oncologist
  • Administered as an intravenous infusion in a clinical setting
  • Frequency usually ranges from every 2 to 3 weeks depending on treatment protocol
  • Dose depends on patient weight, cancer type, and response to therapy

⚠️ This is a prescription-only biologic and must not be self-administered.


Side Effects

Patients may experience some side effects, which vary based on individual response:

  • High blood pressure (hypertension)
  • Fatigue or weakness
  • Risk of bleeding
  • Proteinuria (protein in urine)
  • Delayed wound healing
  • Gastrointestinal complications (rare but serious)
  • Infusion-related reactions

Regular monitoring is essential during treatment.


Global Export Coverage

Cordium Pharmaceuticals Pvt Ltd ensures secure and fast pharmaceutical export supply chain to:

  • United States (USA)
  • Germany
  • United Kingdom (UK)
  • Netherlands
  • United Arab Emirates (UAE)
  • South Africa
  • Brazil

We focus on international compliance, packaging standards, and timely global delivery for healthcare institutions and distributors.


Contact Global Export Team

📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com

Cordium Pharmaceuticals Pvt Ltd – India

 2026-04-18T16:33:30

Other Pages

View all pages